1. Home
  2. NKTX vs PDEX Comparison

NKTX vs PDEX Comparison

Compare NKTX & PDEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nkarta Inc.

NKTX

Nkarta Inc.

HOLD

Current Price

$3.14

Market Cap

188.9M

Sector

Health Care

ML Signal

HOLD

Logo Pro-Dex Inc.

PDEX

Pro-Dex Inc.

HOLD

Current Price

$65.77

Market Cap

189.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NKTX
PDEX
Founded
2015
1978
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
188.9M
189.2M
IPO Year
2020
1995

Fundamental Metrics

Financial Performance
Metric
NKTX
PDEX
Price
$3.14
$65.77
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
1
Target Price
$11.33
$56.00
AVG Volume (30 Days)
749.2K
18.4K
Earning Date
05-11-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
11.88
345.00
EPS
N/A
3.27
Revenue
N/A
$66,593,000.00
Revenue This Year
N/A
$7.22
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$19.40
Revenue Growth
N/A
23.68
52 Week Low
$1.63
$23.52
52 Week High
$3.65
$64.69

Technical Indicators

Market Signals
Indicator
NKTX
PDEX
Relative Strength Index (RSI) 58.80 72.84
Support Level $1.88 $37.43
Resistance Level $3.35 N/A
Average True Range (ATR) 0.21 2.67
MACD -0.01 0.66
Stochastic Oscillator 74.00 100.00

Price Performance

Historical Comparison
NKTX
PDEX

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK-cell expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

About PDEX Pro-Dex Inc.

Pro-Dex Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers (OEMs) to various countries. Its product portfolio includes autoclavable, battery-powered, electric, and multi-function surgical drivers and shavers used mainly in orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, regulatory consulting services, and manufactures rotary air motors utilized in various industries. Operating out of ISO-certified facilities in California, Pro-Dex serves hospitals, medical labs, and high-tech manufacturers, generating revenue through sales of surgical instruments and related services.

Share on Social Networks: